Back to searchBackground Papers0
Result Papers0
Derived Papers0
Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
NCT02444728
PHASE3INTERVENTIONAL
Chinese SLE Treatment And Research Group
50 participants
Started 2015-07 · Completed 2018-12-30
Status: Terminated (as of 12-23-2025)
Conditions
Thrombocytopenia
Interventions
Linked Papers (from SciSciNet-V2)
Total Papers3
Background
0Result
0Derived
0Unknown
3Total Citations Per Year
Brief Summary
Treating severe thrombocytopenia is a challenge in the management of systemic lupus erythematosus. Although rheumatologists have followed some rules in real practice,there is very few evidence to support the current treatment algorithm. The purpose of this study is to compare the complete remission rate and partial remission rate of cyclophosphamide and hydroxychloroquine for treating severe thrombocytopenia in Chinese SLE patients.
Sort by:
Background Papers0
No background papers linked
Result Papers0
No result papers linked
Derived Papers0
No derived papers linked